{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T20:29:31Z","timestamp":1788035371262,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.08.035","type":"journal-article","created":{"date-parts":[[2006,9,6]],"date-time":"2006-09-06T14:32:41Z","timestamp":1157553161000},"page":"649-658","source":"Crossref","is-referenced-by-count":18,"title":["Assessment of the monoterpene, glycidic and triterpene-moieties\u2019 contributions to the adjuvant function of the CP05 saponin of Calliandra pulcherrima Benth during vaccination against experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"25","author":[{"given":"D.","family":"Nico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.N.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.P.","family":"Borja-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Palatnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.B.","family":"Palatnik de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.08.035_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0020-7519(03)00053-5","article-title":"Recent advances in veterinary vaccine adjuvants","volume":"33","author":"Singh","year":"2003","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2006.08.035_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1021\/js9504651","article-title":"Structure-funciton relationship among Quillaja saponins serving as excipient for nasal and ocular delivery of insulin","volume":"85","author":"Pillion","year":"1996","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2006.08.035_bib3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S1359-6446(03)02864-2","article-title":"Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity","volume":"8","author":"Marciani","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2006.08.035_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0167-5699(96)10050-5","article-title":"Covalent chemical events in immune induction: fundamental and therapeutics aspects","volume":"17","author":"Rhodes","year":"1996","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2006.08.035_bib5","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1016\/S0264-410X(01)00142-6","article-title":"Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS21","volume":"19","author":"Waite","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0264-410X(02)00444-9","article-title":"Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis","volume":"21","author":"Santos","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A Phase III trial of Efficacy of the FML- vaccine against canine kala-azar in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante, RN)","volume":"19","author":"da Silva","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib8","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S\u00e3o Gon\u00e7alo do Amarante)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib9","series-title":"Third World Congress on Leishmaniosis (Worldleish III)","first-page":"116","article-title":"Phase I safety and immunogenicity trial of Leishmune \u00ae in dogs of Brazilian endemic areas","author":"Borja Cabrera","year":"2005"},{"key":"10.1016\/j.vaccine.2006.08.035_bib10","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective Immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.57.3.754-763.1989","article-title":"Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate","volume":"57","author":"Palatnik","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.08.035_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0008-6215(99)00294-3","article-title":"Two diastereomeric saponins with cytotoxic activity from Albizia julibrissin","volume":"324","author":"Zou","year":"2000","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2006.08.035_bib13","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1248\/cpb.41.2132","article-title":"Studies on the constitutents of Calliandra anomala (Kunth) Macbr. I. Structure elucidation of two acylated triterpenoidal saponins","volume":"41","author":"Takeda","year":"1993","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.vaccine.2006.08.035_bib14","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.vaccine.2004.08.022","article-title":"Pulcherrimasaponin, from the leaves of Calliandra pulcherrima, as adjuvant for visceral leishmaniasis","volume":"23","author":"Silva","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib15","first-page":"547","article-title":"Experimental murine Leishmania donovani infection: Immunoprotection by the Fucose Mannose Ligand (FML)","volume":"27","author":"Palatnik de Sousa","year":"1994","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2006.08.035_bib16","first-page":"290","article-title":"The FML vaccine (Fucose-Mannose Ligand) protects hamsters from experimental Kala-Azar","volume":"46","author":"Palatnik de Sousa","year":"1994","journal-title":"Ci\u00eancia e Cultura (J Braz Assoc Adv Sci)"},{"key":"10.1016\/j.vaccine.2006.08.035_bib17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1567-5769(01)00016-9","article-title":"Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins","volume":"1","author":"Marciani","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2006.08.035_bib18","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/S0264-410X(02)00209-8","article-title":"QS-21 structure\/function studies: effect of acylation on adjuvant activity","volume":"20","author":"Liu","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib19","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.vaccine.2006.02.034","article-title":"Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis","volume":"24","author":"Oliveira-Freitas","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-2006-958006","article-title":"Haemolytic time course differences between steroid and triterpenoid saponins","volume":"61","author":"Takechi","year":"1995","journal-title":"Planta Med"},{"key":"10.1016\/j.vaccine.2006.08.035_bib21","unstructured":"Bernardo RR. Adjuvant activity of Albizia saman saponins formulated with the FML antigen of Leishmania donovani. PhD Thesis. Federal University of Rio de janeiro, Rio de Janeiro, RJ, Brazil; 1998. p. 121."},{"key":"10.1016\/j.vaccine.2006.08.035_bib22","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0264-410X(96)00292-7","article-title":"Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani","volume":"15","author":"Santos","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0264-410X(92)90435-M","article-title":"Adjuvanticity and ISCOM formation by structurally diverse saponins","volume":"10","author":"Bomford","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib24","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.vaccine.2004.01.072","article-title":"Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins","volume":"22","author":"Palatnik-de-Sousa","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-2006-957962","article-title":"A new triterpenoid saponin, Bredemeueroside B, from Bredemeyera floribunda","volume":"62","author":"Daros","year":"1996","journal-title":"Plant Med"},{"key":"10.1016\/j.vaccine.2006.08.035_bib26","first-page":"167","article-title":"Selection of adjuvant for vaccination against experimental kala-azar. the FML antigen of Leishmania donovani in combination with saponin and sapogenin of Bredemeyera floribunda","volume":"91S","author":"Santos","year":"1996","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2006.08.035_bib27","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0264-410X(97)00139-4","article-title":"Effects of carbohydrate modification of Quillaja saponaria QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity","volume":"15","author":"Ronnberg","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.035_bib28","series-title":"Biochemistry.","author":"Voet","year":"1995"},{"key":"10.1016\/j.vaccine.2006.08.035_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1021\/js9504651","article-title":"Structure-function relationship among Quillaja saponins serving as excipient for nasal and ocular delivery of insulin","volume":"85","author":"Pillion","year":"1996","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2006.08.035_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1360-1385(96)80016-1","article-title":"Saponins and plant defense- a soap story","volume":"1","author":"Osbourn","year":"1996","journal-title":"Trends Plant Sci"},{"key":"10.1016\/j.vaccine.2006.08.035_bib31","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.addr.2004.02.004","article-title":"Current status and potential application of ISCOMs in veterinary medicine","author":"Morein","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2006.08.035_bib32","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0264-410X(95)00077-E","article-title":"Structure\/function studies of QS21 adjuvant: assessment of triterpen-aldehyde and glucuronic acid roles in adjuvant function","volume":"13","author":"Soltysik","year":"1995","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06009911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06009911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T04:33:25Z","timestamp":1587184405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06009911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06009911"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.08.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}